Terms: = Breast cancer AND PER1, O15534, 5187, ENSG00000179094, RIGUI AND Prognosis
4 results:
1. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
2. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
[TBL] [Abstract] [Full Text] [Related]
3. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract] [Full Text] [Related]
4. Disturbance of circadian gene expression in breast cancer.
Kuo SJ; Chen ST; Yeh KT; Hou MF; Chang YS; Hsu NC; Chang JG
Virchows Arch; 2009 Apr; 454(4):467-74. PubMed ID: 19296127
[TBL] [Abstract] [Full Text] [Related]